
CALL FOR SPEAKERS
HELP WRITE THE NEXT BLUEPRINT
Share your expertise. Shape the conversation. Be part of the 2027 DCAT Global Summit.
The DCAT Global Summit Brings Together Industry Professionals from Across the Global Bio/Pharma Ecosystem.
The 2027 DCAT Global Summit is not another industry conference; it is a single-track discussion-led forum with limited seats, candid dialogue and strategic debate among the leaders making the decisions that will define Bio/Pharma for the next decade.
We’re looking for thought leaders, industry and subject-matter experts to share insights and real-world experiences to shape the conversation that goes Beyond the Blueprint.
Why Speak?
Speakers at the Summit aren't presenting to a passive audience; they're leading a conversation with senior leaders, speakers, and subject-matter experts who will push back, ask hard questions, and bring their own experience to the table. This is intimacy and exclusivity by design: smaller, more senior, and more interactive than a typical keynote circuit.
What We’re Looking For:
The sessions are being built around the issues that are keeping global Bio/Pharma leaders up at night:
- Regionalization & Policy — which products, inputs, and technologies now justify regionalization, dual sourcing, or strategic rebalancing
- Europe, Hub vs. Hub — how Basel, Barcelona-Catalonia, Cambridge, and other ecosystems are competing for the next decade of investment, manufacturing expansion, and talent
- Demand Shocks & Modality Shift — what capacity will matter, where investment will flow, and who will fund it
- AI & Decision Speed — how AI, connected data, and supplier visibility are accelerating manufacturing, sourcing, and supply decisions
- Emerging Bio/Pharma — scaling from discovery through commercialization using external manufacturing networks
Format & Opportunities:
Sessions include keynote, moderated debates and panel discussions as part of a single-track program, plus an optional hands-on pre-summit workshop.
*All DCAT events, including the Global Summit, are conducted in compliance with DCAT’s antitrust policy.
